Effects of Small Molecule Inhibitors on MAPK Pathway Dynamics
Author Information
Author(s): Anderson Daniel J., Durieux Jenni K., Song Kyung, Alvarado Ryan, Jackson Peter K., Hatzivassiliou Georgia, Ludlam Mary J. C.
Primary Institution: Genentech, Inc.
Hypothesis
How do small molecule inhibitors affect the dynamics of the MAPK pathway?
Conclusion
The study provides insights into how small molecule inhibitors can activate or inhibit the MAPK pathway in live cells.
Supporting Evidence
- MAPK pathway activation was observed with both single agent and combination studies of Raf and Mek inhibitors.
- Raf inhibitors were shown to cause translocation of CRaf to the plasma membrane.
- Automated image analysis allowed for high-throughput investigation of inhibitor effects.
Takeaway
This study looks at how certain drugs can change the behavior of a cell's signaling system, which is important for understanding cancer treatments.
Methodology
The study used live-cell microscopy and automated image analysis to observe the effects of small molecule inhibitors on the MAPK pathway.
Potential Biases
Potential bias due to the involvement of authors who are employees of the funding organization.
Limitations
The study primarily focuses on specific inhibitors and may not generalize to all MAPK pathway inhibitors.
Statistical Information
P-Value
p=0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website